Dimethyl Sulfoxide Inhibits Tissue Factor Expression, Thrombus Formation, and Vascular Smooth Muscle Cell Activation | Zendy

Giovanni G. Camici | Zendy; Jan Steffel | Zendy; Alexander Akhmedov | Zendy; Nicola Schäfer | Zendy; Jeannette Baldinger | Zendy; Urs Schulz | Zendy; Kushiar Shojaati | Zendy; Christian M. Matter | Zendy; Zhihong Yang | Zendy; Thomas F. Lüscher | Zendy; Felix C. Tanner | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dimethyl Sulfoxide Inhibits Tissue Factor Expression, Thrombus Formation, and Vascular Smooth Muscle Cell Activation

Author(s) -

Giovanni G. Camici,

Jan Steffel,

Alexander Akhmedov,

Nicola Schäfer,

Jeannette Baldinger,

Urs Schulz,

Kushiar Shojaati,

Christian M. Matter,

Zhihong Yang,

Thomas F. Lüscher,

Felix C. Tanner

Publication year - 2006

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.106.638460

Subject(s) - tissue factor , vascular smooth muscle , dimethyl sulfoxide , medicine , microbiology and biotechnology , chemistry , biology , organic chemistry , smooth muscle , coagulation

Subacute stent thrombosis is a major clinical concern, and the search for new molecules to cover stents remains important. Dimethyl sulfoxide (DMSO) is used for preservation of hematopoietic progenitor cells and is infused into patients undergoing bone marrow transplantation. Despite its intravenous application, the impact of DMSO on vascular cells has not been assessed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research